Efficacy of oral prolonged-release mesalazine in moderately active ulcerative colitis

Kristine Paridaens, John R Fullarton, Simon P L Travis

Published in July 2023, Journal of gastroenterology and hepatology

Abstract

New meta‐analyses are presented that provide further evidence supporting the effectiveness of oral prolonged‐release mesalazine compared to other oral mesalazines as induction therapy in patients with moderately active ulcerative colitis.